Literature DB >> 11825923

A rapid ELISA for the diagnosis of intravascular catheter related sepsis caused by coagulase negative staphylococci.

T Worthington1, P A Lambert, A Traube, T S J Elliott.   

Abstract

AIM: To develop and evaluate a rapid enzyme linked immunosorbent assay (ELISA) for the diagnosis of intravascular catheter related sepsis caused by coagulase negative staphylococci.
METHODS: Forty patients with a clinical and microbiological diagnosis of intravascular catheter related sepsis and positive blood cultures, caused by coagulase negative staphylococci, and 40 control patients requiring a central venous catheter as part of their clinical management were recruited into the study. Serum IgG responses to a previously undetected exocellular antigen produced by coagulase negative staphylococci, termed lipid S, were determined in the patient groups by a rapid ELISA.
RESULTS: There was a significant difference (p = < 0.0001) in serum IgG to lipid S between patients with catheter related sepsis and controls. The mean antibody titre in patients with sepsis caused by coagulase negative staphylococci was 10 429 (range, no detectable serum IgG antibody to 99 939), whereas serum IgG was not detected in the control group of patients.
CONCLUSIONS: The rapid ELISA offers a simple, economical, and rapid diagnostic test for suspected intravascular catheter related sepsis caused by coagulase negative staphylococci, which can be difficult to diagnose clinically. This may facilitate treatment with appropriate antimicrobials and may help prevent the unnecessary removal of intravascular catheters.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11825923      PMCID: PMC1769565          DOI: 10.1136/jcp.55.1.41

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  Accuracy and cost-effectiveness of new tests for diagnosis of catheter-related bloodstream infections.

Authors:  B M Farr
Journal:  Lancet       Date:  1999-10-30       Impact factor: 79.321

2.  Central venous catheters and infection. Use of antimicrobial catheters needs to undergo trials.

Authors:  T Elliott; M Faroqui
Journal:  BMJ       Date:  1998-09-05

3.  Routine replacement of central venous catheters: telephone survey of intensive care units in mainland Britain.

Authors:  A M Cyna; J L Hovenden; A Lehmann; K Rajaseker; P Kalia
Journal:  BMJ       Date:  1998-06-27

4.  Rapid diagnosis of catheter-related sepsis using the acridine orange leukocyte cytospin test and an endoluminal brush.

Authors:  M J Tighe; P Kite; D Thomas; W N Fawley; M J McMahon
Journal:  JPEN J Parenter Enteral Nutr       Date:  1996 May-Jun       Impact factor: 4.016

5.  Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures.

Authors:  F Blot; G Nitenberg; E Chachaty; B Raynard; N Germann; S Antoun; A Laplanche; C Brun-Buisson; C Tancrède
Journal:  Lancet       Date:  1999-09-25       Impact factor: 79.321

6.  Evaluation of a novel endoluminal brush method for in situ diagnosis of catheter related sepsis.

Authors:  P Kite; B M Dobbins; M H Wilcox; W N Fawley; A J Kindon; D Thomas; M J Tighe; M J McMahon
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

7.  Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal.

Authors:  P Kite; B M Dobbins; M H Wilcox; M J McMahon
Journal:  Lancet       Date:  1999-10-30       Impact factor: 79.321

8.  Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.

Authors:  D G Maki; S M Stolz; S Wheeler; L A Mermel
Journal:  Ann Intern Med       Date:  1997-08-15       Impact factor: 25.391

9.  Line-associated bacteraemias.

Authors:  T S Elliott
Journal:  Commun Dis Rep CDR Rev       Date:  1993-06-18

Review 10.  Prevention of central venous catheter-related infection.

Authors:  T S Elliott; S E Tebbs
Journal:  J Hosp Infect       Date:  1998-11       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.